Authors:
MAZAL A
SCHWARTZ L
LACROIX F
MAMMAR H
DELACROIX S
FERRAND R
NAURAYE C
DESJARDINS L
SCHLIENGER P
DHERMIES F
FRAU E
HABRAND JL
ROSENWALD JC
Citation: A. Mazal et al., A PRELIMINARY COMPARATIVE TREATMENT PLANNING STUDY FOR RADIOTHERAPY OF AGE-RELATED MACULOPATHY, Radiotherapy and oncology, 47(1), 1998, pp. 91-98
Authors:
COUCKE PA
ZOUHAIR A
OZSAHIN M
DETRIBOLET N
MIRIMANOFF RO
Citation: Pa. Coucke et al., FOCALIZED EXTERNAL RADIOTHERAPY FOR RESECTED SOLITARY BRAIN METASTASIS - DOES THE DOGMA STAND, Radiotherapy and oncology, 47(1), 1998, pp. 99-101
Citation: P. Davey et B. Ngan, PATIENTS WITH BRAIN FAILURE WHO DO NOT RECOVER NEUROLOGICALLY DESPITEHAVING NO EVIDENCE OF TUMOR, Radiotherapy and oncology, 47(1), 1998, pp. 103-103
Citation: M. Baumann, IS CURATIVE RADIATION-THERAPY IN ELDERLY PATIENTS LIMITED BY INCREASED NORMAL TISSUE TOXICITY, Radiotherapy and oncology, 46(3), 1998, pp. 225-227
Authors:
CHAPMAN JD
ENGELHARDT EL
STOBBE CC
SCHNEIDER RF
GERALD GE
Citation: Jd. Chapman et al., MEASURING HYPOXIA AND PREDICTING TUMOR RADIORESISTANCE WITH NUCLEAR-MEDICINE ASSAYS, Radiotherapy and oncology, 46(3), 1998, pp. 229-237
Authors:
PIGNON T
GREGOR A
KONING CS
ROUSSEL A
VANGLABBEKE M
SCALLIET P
Citation: T. Pignon et al., AGE HAS NO IMPACT ON ACUTE AND LATE TOXICITY OF CURATIVE THORACIC RADIOTHERAPY, Radiotherapy and oncology, 46(3), 1998, pp. 239-248
Authors:
GERARD JP
AYZAC L
HUN D
ROMESTAING P
COQUARD R
ARDIET JM
MORNEX F
Citation: Jp. Gerard et al., TREATMENT OF ANAL-CANAL CARCINOMA WITH HIGH-DOSE RADIATION-THERAPY AND CONCOMITANT FLUOROURACIL-CISPLATINUM - LONG-TERM RESULTS IN 95 PATIENTS, Radiotherapy and oncology, 46(3), 1998, pp. 249-256
Authors:
LEPECHOUX C
ARRIAGADA R
LECHEVALIER T
TARAYRE M
RUFFIE P
BALDEYROU P
BRETEL JJ
PELLAECOSSET B
HANZEN C
MARTIN M
DUROUX P
Citation: C. Lepechoux et al., ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER, Radiotherapy and oncology, 46(3), 1998, pp. 257-261
Citation: A. Dasu et J. Denekamp, NEW INSIGHTS INTO FACTORS INFLUENCING THE CLINICALLY RELEVANT OXYGEN ENHANCEMENT RATIO, Radiotherapy and oncology, 46(3), 1998, pp. 269-277
Authors:
LATZ D
SCHULZE T
MANEGOLD C
SCHRAUB P
FLENTJE M
WEBER KJ
Citation: D. Latz et al., COMBINED EFFECTS OF IONIZING-RADIATION AND 4-HYDROPEROXYIFOSFAMIDE IN-VITRO, Radiotherapy and oncology, 46(3), 1998, pp. 279-283
Authors:
WHELDON TE
DEEHAN C
WHELDON EG
BARRETTA A
Citation: Te. Wheldon et al., THE LINEAR-QUADRATIC TRANSFORMATION OF DOSE-VOLUME HISTOGRAMS IN FRACTIONATED RADIOTHERAPY, Radiotherapy and oncology, 46(3), 1998, pp. 285-295
Authors:
POWERS BE
THAMES HD
GILLETTE SM
SMITH C
BECK ER
GILLETTE EL
Citation: Be. Powers et al., VOLUME EFFECTS IN THE IRRADIATED CANINE SPINAL-CORD - DO THEY EXIST WHEN THE PROBABILITY OF INJURY IS LOW, Radiotherapy and oncology, 46(3), 1998, pp. 297-306
Citation: Je. Moulder et al., RADIATION NEPHROPATHY IS TREATABLE WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR AN ANGIOTENSIN-II TYPE-1 (AT(1)) RECEPTOR ANTAGONIST, Radiotherapy and oncology, 46(3), 1998, pp. 307-315
Authors:
FROSCHLE G
ZIERON JO
CARL UM
BECKBORNHOLDT HP
Citation: G. Froschle et al., COMBINED-MODALITY TREATMENT OF BONE METASTASES - RESPONSE OF THE RHABDOMYOSARCOMA R1H OF THE RAT TO POSTOPERATIVE IRRADIATION COMBINED WITHLOCAL RELEASE OF DAUNORUBICIN FROM ACRYLIC CEMENT, Radiotherapy and oncology, 46(3), 1998, pp. 317-320
Authors:
RAAIJMAKERS CPJ
BRUINVIS IAD
NOTTELMAN EL
MIJNHEER BJ
Citation: Cpj. Raaijmakers et al., A FAST AND ACCURATE TREATMENT PLANNING METHOD FOR BORON NEUTRON-CAPTURE THERAPY, Radiotherapy and oncology, 46(3), 1998, pp. 321-332
Citation: M. Vanhinsberg, BIOLOGICAL EQUIVALENCE OF STEPPING SOURCE VERSUS WIRE SOURCE DOSAGE ACCORDING TO THE LQ MODEL, Radiotherapy and oncology, 46(3), 1998, pp. 333-334
Citation: Db. Mclaren et Md. Mason, HYPOFRACTIONATED RADIOTHERAPY FOR MUSCLE INVASIVE BLADDER-CANCER IN THE ELDERLY, Radiotherapy and oncology, 46(3), 1998, pp. 335-335
Citation: M. Baumann et al., HYPERFRACTIONATED RADIOTHERAPY IN HEAD AND NECK-CANCER - A 2ND LOOK AT THE CLINICAL-DATA, Radiotherapy and oncology, 46(2), 1998, pp. 127-130